Book summary “Next”: summary

Introduction

You live in a world where the boundaries between commercial property and the human body dissolve every day. Venture capitalists, academic researchers, and pharmaceutical executives race to colonize the human genome. They transform your biological material, your genetic history, and the natural world into patentable commodities. You might assume that your DNA belongs to you, but the legal system and the biotechnology industry treat your physical form as an open-source warehouse for corporate profit.

The biotechnology industry is rapidly commercializing the human genome and nature itself through aggressive patenting, corporate greed, and ethical violations that threaten personal freedom and common heritage.

Michael Crichton exposes this wild west of modern science through a narrative web of venture capital greed, genetic espionage, and bioethical collapse. You will see how laboratories smuggle transgenic embryos, pathology labs traffic in human body parts, and patent offices hand over chunks of your DNA to private corporations. The book traces these crises across sixteen interconnected domains, examining how genetic testing infiltrates family law, how gene patents choke off life-saving medical research, and how corporations attempt to brand the natural world itself. You will discover the dark reality behind academic fraud, media hype, and corporate security failures that leave proprietary genetic databases wide open to theft.

• Who truly owns the building blocks of your body and the natural world?
• How do biotechnology companies bypass ethical boundaries to patent human genes?
• What happens when your genetic code becomes a legal weapon in courtrooms and corporate boardrooms?

1. Biotech Venture Capital and Genomic Theft

Venture capitalists invest billions into the biotechnology sector with the expectation of replacing traditional pharmaceutical companies. You can see how this explosive financial trajectory attracts immense capital and drives aggressive competition across the industry.

Venture capitalists pump billions into the biotechnology sector while rogue employees smuggle transgenic embryos out of laboratories for illicit sale.

The BioChange Conference

Venture capitalist Jack B. Watson delivered an enthusiastic keynote address at the BioChange 2006 Conference in Las Vegas. He emphasized the massive growth of the sector to an audience of two thousand attendees.

The industry relies on aggressive funding sources:

• four billion a year in federal grants to universities;
• five billion a year in venture capital investments;
• sixty billion in projected industry revenue for the current year;
• two hundred billion for next year;
• five hundred billion in five years.

Embryo Smuggling

Postdocs and biotech workers sometimes turn against their employers to sell valuable genetic materials to illicit buyers. These biological assets require extreme cold via liquid nitrogen dewars to remain viable during transport.

Eddie Tolman, a thirty-year-old postdoc from MicroProteonomics in Cambridge, Massachusetts, stole twelve transgenic embryos. Five days after leaving Cambridge, he transported them to the conference in Las Vegas using a cryogenic dewar. A fugitive-recovery specialist named Vasco Borden, who was forty-nine years old, tracked such illicit activities across the commercialized landscape.

2. Cell Line Ownership and Legal Battles

Medical researchers and institutions claim absolute ownership over cell lines extracted from patients, stripping individuals of any rights to the immense commercial profits generated from their bodies.

When medical researchers extract tissues to develop treatments, courts often classify the resulting materials as discarded waste. Consequently, you cannot claim a share of the immense commercial profits generated by biotechnology companies using your biological samples.

The Burnet Cell Line

Frank Burnet began construction work and fell ill eight years ago. He continued going to UCLA for testing for four years. Six years had passed since Burnet was diagnosed with leukemia when he discovered the truth.

He sued the Regents of the University of California after learning that his doctor, Michael Gross, commercialized a cytokine-producing cell line derived from his body without proper consent. The resulting Burnet cell line reached an estimated value of three billion dollars.

Discarded Waste Fallacy

A nationwide and international black market exists for illegal tissue harvesting and organ trafficking from cadavers. Medical facilities and pathology laboratories have been implicated in stealing bones, organs, and tissue from deceased patients and selling them to tissue banks and biomedical companies, forging death certificates to cover up the thefts.

Dr. Martin Roberts, chief administrator of the pathology laboratory at Long Beach Memorial Hospital, was charged with 143 counts of illegally harvesting and selling body parts from cadavers. Investigators uncovered systemic abuses across major facilities:

• UCLA Medical Center had 500 bodies cut up and sold for $700,000;
• pathology labs forged death certificates to hide missing tissue;
• commercial brokers funneled human remains directly into private tissue banks.

3. Family Law and Genetic Testing

Litigators introduce extensive genetic panels into family law proceedings to gain tactical advantages in child custody and divorce cases. You watch as personal biology becomes a weapon in bitter domestic disputes.

Attorneys integrate extensive genetic panels into child custody proceedings and divorce cases to gain tactical advantages by weaponizing predispositions to diseases and behavioral traits.

Attorneys leverage genetic predispositions for diseases like Alzheimer's or Huntington's, as well as behavioral tendencies, to argue that an opposing spouse is unfit to serve as a primary caregiver. This strategy expands litigation, increases legal fees, and generates intense conflict.

Custody Proceedings

Divorce lawyer Barry Sindler incorporated comprehensive genetic testing into the custody proceedings between Rick Diehl and his wife, Karen Diehl.

Law firms utilize an extensive array of diagnostic tools:

• twelve hundred gene tests available as genetic panels;
• BRCA genes indicating cancer risks;
• the novelty gene linked to behavioral tendencies.

Karen Diehl was twenty-eight years old when her medical data entered the legal battle. Attorneys also analyzed a fifty-fifty chance of inheriting Huntington's disease from an affected ancestor to challenge parental competence.

Genetic Litigation

The widespread adoption of genetic testing in custody battles and insurance underwriting has created severe ethical backlashes and legal controversies. You see private medical data leaking directly into courtrooms.

Attorney Barry Sindler faces intense public backlash and a personal divorce after pioneering genetic testing practices for custody cases. Meanwhile, insurance companies drive the demand for genetic testing to minimize payout liabilities, despite the risk of violating personal health privacy. Litigation costs escalate rapidly, matching expenses like a five hundred thousand dollar cost of a single kitchen renovation.

4. Scientific Integrity and Media Hype

Academic institutions, scientific journals, and media outlets promote sensationalized or completely fabricated breakthroughs to secure funding, while peer review fails to catch scientific fraud.

American science employs three million researchers. Scientific fraud costs an estimated thirty billion dollars annually across the sector. Academic institutions, journals, and researchers benefit financially from sensationalized claims about stem cell research and genetic discoveries. Peer review frequently fails to catch altered data, falsified databases, and outright scientific fraud.

Korean biochemist Hwang Woo-Suk fabricated research papers published in Science magazine regarding human embryonic stem cells created through somatic nuclear transfer. Hwang spent eighteen hours a day in the lab to project relentless dedication. The intense pressure to produce results leads researchers to bypass ethical standards and fabricate data.

Media outlets repeatedly publish false studies predicting the extinction of the blonde hair gene. This fabricated urban legend has persisted for over a century. The World Health Organization denied ever conducting or publishing any study predicting blonde hair extinction. Investigators traced the false news story back through a German wire service and a women's magazine. Media observers attribute this longevity to poor fact-checking and the preference for sensationalist stories over accuracy.

• 150 years of repeated false blonde extinction stories
• 600 years predicted until blonde extinction

An 1906 lecture by Major C. E. Woodruff at Columbia University predicted that blondes would be completely extinct within six hundred years. You see sensational headlines override basic fact-checking across major news networks.

5. Retroviral Experimentation and Behavioral Modification

Laboratories experiment with bioengineered retroviruses designed to target specific genes, creating severe biological hazards when experimental agents accidentally contaminate human subjects.

BioGen Research Labs

Researchers develop gene-laced viral delivery systems to modify neurological pathways in animal subjects. You see laboratories explore links between genetics and neurodegenerative conditions using these tools. Accidental exposure to these experimental retroviruses can inadvertently affect human subjects.

BioGen maintained forty thousand square feet of shed space for animal storage.

Josh Winkler administered a retrovirus carrying the maturity gene ACMPD 3N7 to lab rats using an eight-hundred-gram standard weight to calculate dosages. His thirty-year-old drug-addicted brother Adam accidentally inhaled a dose from a discarded cylinder.

Maturity Genes

Commercial biotechnology ventures seek to isolate and patent genes regulating complex human social behaviors and psychological states. Researchers isolate genes that influence prefrontal cortex activity, social harmony, and group cohesion. You can observe firms aiming to market them as therapeutic solutions or medical treatments while facing heavy public controversy.

Columbia University researchers isolated a gene promoting conventional wisdom and sociability. This discovery led to intense bidding from pharmaceutical giants to license it under commercial names like the comfort gene.

Estimated proportions show that ninety-two percent of people carry the conventional-wisdom gene.

6. Evolutionary Genetics and Hybridization

Genomic sequencing reveals that human ancestors continued interbreeding with chimpanzees for millions of years before speciation became permanent.

The Human-Chimp Split

Analysis of the human genome reveals fewer genetic differences than previously expected. Rapid evolutionary changes on the X chromosome highlight this shift. You can observe how hybridization played a significant role in early human evolution before speciation became permanent.

Common ancestors walked the earth eighteen million years ago. Gibbons split off sixteen million years ago. Orangutans split off twelve million years ago, and gorillas split off ten million years ago. Chimpanzees and humans initially split nine million years ago.

Harvard and MIT geneticists concluded that ancestral humans continued breeding with chimpanzees until 5.4 million years ago. The genetic difference between humans and chimpanzees stands at 1.5 percent. Researchers count five hundred genes in all that differentiate the two species.

Evolutionary Timelines

Anthropologists trace specific behavioral traits back to archaic hominids. You may notice how genetic remnants influence modern resistance to technological or environmental innovation.

Sheldon Harmon extracted a gene from Neanderthal skeletons. He claimed it predisposed the species to resist rapid change and environmental disruption.

Other genetic variants emerged rapidly due to sexual selection. Canadian anthropologist Peter Frost published a study in Evolution and Human Behavior concluding that European women evolved blond hair and blue eyes at the end of the last Ice Age. Light pigmentation acted as a biological marker for high estrogen levels and fertility when women competed for scarce male mates. The hair color gene MC 1R evolved variants 11000 years ago. A disputed World Health Organization study predicted the demise of blondes by the year 2202, estimating a two hundred year timeline for the extinction of natural blondes.

7. Pathology Labs and Body Part Trafficking

Hospital morgues and pathology facilities are vulnerable to underground trade networks that illegally harvest and sell human bones from corpses. A nationwide and international black market exists for illegal tissue harvesting and organ trafficking from cadavers.

Hospital morgues and pathology facilities are compromised by underground black markets that illegally harvest and sell human bones from deceased patients.

Medical facilities and pathology laboratories have been implicated in stealing bones, organs, and tissue from deceased patients and selling them to tissue banks and biomedical companies. Forgers falsify documents to cover up the thefts.

Pathologists and mortuary assistants exploit exhumations and nighttime access to remove long bones from bodies to fulfill urgent orders from commercial bone banks. These operators cover up their actions by using wooden dowels or fabricated hospital records.

At Long Beach Memorial Hospital, an assistant named Raza and his brother secretly harvested long bones from bodies brought in for autopsies. They replaced the missing bones with wooden dowels or even lead pipes.

Dr. Martin Roberts, chief administrator of the pathology laboratory at Long Beach Memorial Hospital, was charged with 143 counts of illegally harvesting and selling body parts from cadavers.

Illegal tissue operations involve multiple methods:

• intercepting bodies brought in for autopsies;
• responding to a stat call for bone;
• utilizing the diener network to access corpses;
• forging death certificates to hide missing parts.

At UCLA Medical Center, perpetrators had 500 bodies cut up and sold for $700,000. Technicians took thirty cc's of frozen venous blood for a patient sample before extracting bones. They extracted long bones eight days ago in some cases before the theft was discovered.

8. Corporate Security and Genomic Espionage

Negligent security management and compromised insiders leave proprietary genetic databanks and corporate facilities vulnerable to massive digital and physical thefts.

Biotech companies face severe internal security risks, including disabled surveillance systems and compromised insider personnel. You might assume that multi-million dollar genomics facilities maintain impenetrable defenses, but corporate negligence often tells a different story.

• Negligent security management and nepotism allow unauthorized individuals to access secure facilities;
• security cameras can remain disabled for months without intervention;
• proprietary genetic databanks remain vulnerable to massive digital and physical thefts.

At BioGen Research, security cameras in the parking lot were broken for two months. Chief of security Bradley Gordon neglected his duties and was eventually arrested in a targeted blackmail setup. Security personnel checked surveillance footage spanning only forty-eight hours in certain investigations, missing long-term breaches by sophisticated actors.

Competitor genomics labs suffer devastating data breaches when insiders bypass internal firewalls. Attackers successfully removed fifty terabytes of network data from a competitor genomics lab in a single coordinated operation. The Biological Data Group and similar corporate entities operate like submarine commanders navigating blind when internal surveillance fails entirely.

9. Gene Patenting and Commercializing Nature

Patent offices grant thousands of DNA-based patents annually, allowing private entities to own significant percentages of the human genome and obstruct medical research.

Submarine Patents

University research labs and institutions like the University of California hold massive portfolios of gene patents. These patents cover conditions ranging from metabolic disorders to behavioral traits. You watch as institutions use vague, dormant patent applications to control downstream research and clinical applications.

Legal rulings have failed to properly address genetic patents for two decades. Companies and research institutions patent naturally occurring genes, enzymes, and proteins. You see entities claiming ownership over biological facts of nature.

Restricting Clinical Care

This practice creates absurd legal barriers throughout the medical industry. Companies might own a cell but not all the genes inside it. Third parties hold patents on essential promoter genes required to manufacture a pharmaceutical product.

Duke University holds a patent for the gene TLA 4A. This gene controls the manufacture of BioGen's anticarcinogenic product. The patent legally blocks BioGen from using its own cell line's product without a license.

Granting a patent on a gene creates an undeserved monopoly on pure information that already exists in nature. This monopoly halts further innovation and harms patient care. You face the consequences when patent owners restrict diagnostic testing:

• Myriad patented two breast cancer genes and charged nearly three thousand dollars for the test.
• The owner of the Canavan disease gene refused to make the test widely available.
• Three simultaneous patent claims on SARS inhibited research during the ten percent death rate outbreak.

Genes form part of the common human heritage. Treating them as private commercial property creates legal traps that threaten public health. Five hundred genetic diseases are potentially curable by gene therapy, but patent thickets obstruct the path.

10. Transgenic Animals and Interspecies Experiments

Inserting human genes into animal embryos yields unexpected cognitive advancements and linguistic capabilities, crossing profound ethical boundaries.

At the Institut National in Paris, a transgenic African grey parrot named Gerard received human genes as a chick. By two years old, Gerard learned to perform arithmetic and accurately solved subtraction problems for a young student.

The Transgenic Chimp Dave

Henry Kendall inserted his own human genes into a chimpanzee embryo during a sabbatical. He expected an early miscarriage so he could dissect the fetus. Instead, the surrogate gave birth to a full-term infant chimp with human traits and the ability to speak. The genome reveals only a 1.5 percent difference separating humans and chimpanzees, accounting for about 500 genes.

Fearing political scandal and loss of funding, facility director Rovak plans to euthanize the animal. Henry rescues him and disguises his identity as a rare medical syndrome. Henry hides the chimp named Dave by bringing him home to his family and passing him off as a human child suffering from Gandler-Kreukheim syndrome.

Experimental Parrots

Children engineered with non-human genetic material display instinctive defensive responses that strain traditional parenting methods. These behaviors draw police attention and cause violent conflicts with peers.

Dave, a child with chimpanzee DNA living with Lynn and Henry, violently defends himself and Jamie against sixth-grade bullies by biting and throwing feces before fleeing up a tree.

11. The Commercialization of Nature and Genomes

Advertising executives and biotech firms propose genomic advertising and transgenic consumer products to commercialize living species and brand the natural world.

You face an environment where traditional advertising loses effectiveness. The average American already encounters 3,000 commercial messages daily.

Genomic Advertising

Corporations seek fresh canvases by modifying living organisms and atmospheric elements. You can brand the natural world directly using biotech methods:

• Cadbury clown fish
• British Petroleum coral
• 900-foot-high cloud letters generated by nanoparticles

Gavin Koss presents these concepts to a London advertising agency. His proposals include nanoswarm clouds using bacteria to project slogans across the sky.

Transgenic Pets and Art

Contemporary artists and biotech firms collaborate to engineer novelty organisms. You can purchase modified life forms marketed as consumer novelties or artistic statements.

Artist Lisa Hensley partners with Borger and Snodd Ltd. to breed giant three-foot-long cockroaches as household pets. These engineered insects stand one foot off the ground.

Firms like Kumnick Genomics develop Perma-Puppies that never grow up.

Artists also exploit bodily waste to create high-priced stunts. Gianni Motti purchases liposuction fat from Italian Prime Minister Silvio Berlusconi. Motti molds the fat into a bar of soap named Mani Pulite and sells it to a private collector for $18,000.

12. Genetic Defenses and Legal Responsibility

Attorneys increasingly introduce genetic predispositions in criminal trials to argue that defendants lack impulse control, shifting moral responsibility from the individual to biology.

The Novelty Gene Defense

Legal strategy shifts when attorneys bring cellular biology into the courtroom. You watch standard arguments about intent give way to claims about inherited traits. Criminal behavior appears as the inevitable result of microscopic biological abnormalities.

Defense teams attempt to classify high-risk actions as uncontrollable physiological responses. Biology replaces free will as the primary driver of unlawful conduct.

Dopamine Receptors

Attorneys focus on specific genetic markers to excuse reckless acts. The D4DR novelty gene governs dopamine levels and regulates thrill-seeking tendencies.

Attorney Willy Johnson plans a genetic defense for Brad Gordon by arguing that his client's thrill-seeking behavior and legal charges stem from an irresistible genetic impulse.

The defendant faces 20 years in prison. The record shows 5 speeding tickets accumulated by the defendant in three years.

13. Epigenetics and the Complexity of Behavior

The traditional view that single genes directly dictate specific human behaviors is fundamentally flawed due to complex gene-environment interactions.

You might assume that a single piece of DNA determines a specific trait or action. Geneticists note that there is no single agreed-upon definition of a gene. DNA sequences can code for multiple proteins, act as regulatory switches, or remain silent until activated by specific environmental stimuli. Epigenetic studies focus on how genes and environments interact dynamically.

The human genome contains 35,000 genes. Researchers have identified 96 genes involved in diabetes. Popular concepts fail to hold up under rigorous scientific verification.

Professor William Garfield explains to congressional aides that popular concepts like a gay gene, violence gene, or sleep gene have failed to hold up under rigorous scientific verification.

Redefining the Gene

You encounter complex biological realities that defy simple genetic determinism. The D4DR gene and the novelty gene do not operate in a vacuum.

Environmental Triggers

Epigenetic studies reveal that behavior emerges from continuous dialogue between biology and surroundings. You must look beyond simple sequences to understand living systems.

14. Sperm Donation Liabilities and Reproductive Commodification

Advanced genealogy and database searches allow adults born from artificial insemination to track down anonymous biological fathers and hold them legally liable for child support.

Anonymity guarantees for historical sperm donors are breaking down as advanced genealogy and database searches allow children born from artificial insemination to track down biological fathers and sue them. Adult children use historical records, university yearbooks, and genetic testing kits to match their DNA against stored blood or commercial databases. You witness biological fathers held legally liable for child support and genetic predispositions regardless of initial agreements.

Elizabeth Murphy confronts Dr. Martin Bennett in Chicago with a genetic report proving he is her biological father from an anonymous donation made 30 years prior at a St. Louis medical school clinic. She is 28 years old, utilizing a 120-students-per-class historical yearbook and the original 25 dollars paid for a sperm donation to track down markers like AGS3 and DAT 1.

Breaking Donor Anonymity

You see the collapse of historical protections as courts override past contracts. Legal precedents shift to favor biological claims over institutional promises of privacy.

Teenage Egg Sellers

Teenagers exploit relaxed legal frameworks around reproductive issues to sell their eggs or genetic material for personal profit without parental notification or consent. Minors utilize fertility clinics to undergo hormone treatments and extract eggs to sell for cash. You find doctors protecting this practice behind doctor-patient privilege and reproductive rights laws that prevent parents from accessing medical records.

Georgia Bellarmino discovers hidden fertility drug syringes in her 16-year-old daughter Jennifer's attic space, but the police and doctor refuse to inform her due to medical privacy laws. Jennifer injected medications like LUPRON, GONAL-F, and FOLLESTIM to prepare for commercial extraction.

15. Gene Therapy Failures and Public Backlash

Early corporate gene therapy trials are fraught with high mortality rates, while biotechnology companies attempt to conceal patient deaths behind trade secret claims.

Concealing Casualties

You see biotechnology companies protect experimental procedures with aggressive legal shields. Safety failures and fatal complications are routinely classified to protect corporate interests.

Aaron discusses how 600 known deaths occurred during early gene therapy trials starting in the 1980s. Institutions and firms hide these casualties under the guise of proprietary information. They continue billing medical systems for procedures that result in fatal outcomes while utilizing trade secret laws to silence critics.

Public Distrust

Public sentiment toward the industry turns overwhelmingly hostile. You discover that ordinary citizens view corporate researchers as unscrupulous actors who prioritize profits over human life.

Opinion polls run 92 percent against biotech companies. This intense anger stems from specific corporate practices:

• patenting genes;
• inflating research costs;
• environmental contamination;
• exploiting common genetic heritage.

When transgenic integration becomes public knowledge, affected households face extreme scrutiny. The Kendall family of La Jolla is featured in a People magazine article titled "The Modern Family", detailing their transgenic household. Religious leaders like Reverend Billy John Harker denounce Henry Kendall as Satan incarnate, subjecting transgenic families to sensationalized media circuses and protests.

16. Orphan Diseases and Corporate Greed

Pharmaceutical giants set prohibitive licensing fees for gene patents, leaving rare genetic deficiency diseases completely unresearched and patients without life-saving treatments.

Vogelman's Paresis

Rare genetic deficiency diseases go completely unresearched by laboratories because pharmaceutical conglomerates buy up and lock away the associated genes. When you contract a condition caused by a point mutation in a repair gene, treatment is virtually impossible.

Philanthropist Jack Watson contracts Vogelman's paresis, a fatal neurodegenerative condition caused by a mutation in the BRD7A gene. He discovers no laboratories are researching treatments because the gene is locked up by a Swiss pharma giant. There are an estimated 50,000 worldwide cases of Vogelman's paresis annually. Scripps isolated the BRD7A gene 5 years ago, yet Jack Watson has a remaining life expectancy of 4 months upon diagnosis.

Locked-Up Genomes

Medical research grinds to a halt under corporate bureaucracy and exorbitant costs. You find that essential materials remain out of reach for independent researchers trying to save dying patients.

• Pharmaceutical conglomerates buy up gene patents behind massive bureaucracy;
• exorbitant fees prevent independent laboratories from studying cures;
• Beinart Baghoff controls and restricts 800 genes through its licensing division.

1. Demand comprehensive legal reforms that prohibit the patenting of human genes, cell lines, and natural organisms to keep the common biological heritage accessible for medical research.
2. Insist on absolute bodily autonomy and property rights over your own tissues, cells, and genetic data to prevent medical institutions and corporations from profiting off your physical remains without consent.
3. Reject the use of genetic predispositions and behavioral panels in family law, child custody proceedings, and criminal trials to prevent biological determinism from eroding personal accountability and fairness.
4. Support stringent regulatory oversight and transparent reporting for all laboratories conducting retroviral research, transgenic experiments, and human-animal hybridization to eliminate catastrophic biological hazards.
5. Hold pharmaceutical companies accountable for exorbitant licensing fees on rare disease treatments and demand public investment in independent research to ensure life-saving medications reach every patient in need.

10 Key Ideas

1. Legal systems and biotechnology industries must prohibit the patenting of human genes to keep the common biological heritage accessible for medical research.
2. Medical institutions and corporations must not claim absolute ownership over cell lines extracted from patients to strip individuals of rights to commercial profits.
3. The abolition of the Bayh-Dole Act would prevent universities from patenting federally funded discoveries and restricting downstream research.
4. Venture capitalists pump billions into the biotechnology sector while rogue employees smuggle transgenic embryos out of laboratories for illicit sale.
5. Advanced genealogy and database searches allow adults born from artificial insemination to track down anonymous biological fathers and hold them legally liable for child support.
6. Epigenetic studies reveal that behavior emerges from continuous dialogue between biology and surroundings rather than single genes directly dictating specific human actions.
7. Biotechnology companies attempt to conceal patient deaths and safety failures during early gene therapy trials behind trade secret claims.
8. Pharmaceutical giants set prohibitive licensing fees for gene patents, leaving rare genetic deficiency diseases completely unresearched and patients without life-saving treatments.
9. Government research bans on embryonic stem cell work drive scientists underground or abroad while failing to stop the commercialization of science.
10. Medical data transparency ensures that academic institutions, scientific journals, and media outlets are held accountable for fabricating breakthroughs and failing peer review.